Pricing Log in Create free account

Abpro Holdings Inc. (ABPO) vs PMGC Holdings Inc. (ELAB)

Abpro Holdings Inc. and PMGC Holdings Inc. are both Biotechnology companies. Abpro Holdings Inc. and PMGC Holdings Inc. are of similar size ($1.4M and $1.3M). PMGC Holdings Inc. has negative trailing earnings, so its P/E is not meaningful; Abpro Holdings Inc. trades at 0.5×. Abpro Holdings Inc. has the higher net margin (0.00% vs −523.0%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, Abpro Holdings Inc. leads on 10 and PMGC Holdings Inc. on 2.

Valuation

Metric ABPO ELAB Biotechnology median
P/E 0.55 n/m 10.60
P/S n/m 0.31 9.40
P/B n/m 0.05 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.16 1.58 0.66
EV/Sales n/m (6.87) 9.02
Earnings yield 183.50% (127,538.28%) (32.88%)
Free cash flow yield (193.29%) (1,131.30%) (23.13%)

Profitability

Metric ABPO ELAB Biotechnology median
Gross margin — 31.08% 68.51%
Operating margin 0.00% (458.63%) 0.00%
Net margin 0.00% (522.99%) 0.00%
Free cash flow margin 0.00% (348.69%) 0.00%
Return on equity (20.18%) (104.60%) (51.96%)
Return on assets 46.10% (58.71%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ABPO ELAB Biotechnology median
Revenue growth (TTM) — 5.41% 6.76%
EPS growth (last fiscal year) 94.15% 94.22% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric ABPO ELAB Biotechnology median
Debt to equity 0.00 0.02 0.00
Current ratio 0.62 1.36 4.97
Net debt to EBITDA 0.01 0.87 1.01

Dividend

Metric ABPO ELAB Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ABPO ELAB Biotechnology median
Market cap 1.42m 1.33m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack